The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Magkou, D., & Tziomalos K. (2014).  Antidiabetic treatment, stroke severity and outcome.. World J Diabetes. 5(2), 84-8.
Addabbo, F., Baglioni V., Schrag A., Schwarz M. J., Dietrich A., Hoekstra P. J., et al. (2020).  Anti-dopamine D2 receptor antibodies in chronic tic disorders.. Dev Med Child Neurol. 62(10), 1205-1212.
Fountoulakis, K. N., Gonda X., Samara M., Siapera M., Karavelas V., Ristic D. I., et al. (2012).  Antiepileptic drugs and suicidality.. J Psychopharmacol. 26(11), 1401-7.
Siamouli, M., Samara M., & Fountoulakis K. N. (2014).  Is antiepileptic-induced suicidality a data-based class effect or an exaggeration? A comment on the literature.. Harv Rev Psychiatry. 22(6), 379-81.
Hostettler, K. E., Zhong J., Papakonstantinou E., Karakiulakis G., Tamm M., Seidel P., et al. (2014).  Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.. Respir Res. 15, 157.
Saoulidis, S., Simitsopoulou M., Dalakiouridou M., Walsh T. J., L Wheat J., Papaioannidou P., et al. (2011).  Antifungal activity of posaconazole and granulocyte colony-stimulating factor in the treatment of disseminated zygomycosis (mucormycosis) in a neutropaenic murine model.. Mycoses. 54(5), e486-92.
Saoulidis, S., Simitsopoulou M., Dalakiouridou M., Papaioannidou P., & Roilides E. (2008).  Antifungal Activity of Posaconazole and Granulocyte Colony-Stimulating Factor in the Treatment of Disseminated Zygomycosis in a Neutropenic Murine Model. International Journal of Infectious Diseases. 12, S48.
Rizava, C., Bekiari E., Liakos A., Sarigianni M., Rika M., Haidich A. Bettina, et al. (2016).  Antigen-based immunotherapies do not prevent progression of recent-onset autoimmune diabetes: a systematic review and meta-analysis. Endocrine. 541493253564319603435853315343646323232332378366375452107937693091093863(331029229844492951104144411978855372514249), 620 - 633.
Dionyssiou, D., & Demiri E. (2008).  Antihelix, antehelix or anthelix? Comments on ‘Upping the Anti?’. Journal of Plastic, Reconstructive & Aesthetic Surgery. 61(10), 1231.
Dionyssiou, D., & Demiri E. (2008).  Antihelix, antehelix or anthelix? Comments on 'Upping the Anti?'.. J Plast Reconstr Aesthet Surg. 61(10), 1231.
Imprialos, K. P., Stavropoulos K., & Doumas M. (2018).  Antihypertensive drug treatment: the real-life challenge.. J Clin Hypertens (Greenwich). 20(1), 115-117.
Boutari, C., Stavropoulos K., Imprialos K. P., Petidis K., & Doumas M. (2016).  Antihypertensive Drug-Related Side Effects: Is It the Unique Indicator for Nonadherence?. Am J Hypertens. 29(5), 662.
Nikolaidou, B., Lazaridis A., & Doumas M. (2014).  Antihypertensive therapy after acute ischemic stroke.. JAMA. 311(22), 2333-4.
Georgianou, E., Georgianos P. I., Petidis K., Athyros V. G., Sarafidis P. A., & Karagiannis A. (2018).  Antihypertensive therapy in acute ischemic stroke: where do we stand?. J Hum Hypertens. 32(12), 799-807.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2009).  Anti-inflammatory effects of fibrates: an overview.. Curr Med Chem. 16(6), 676-84.
Kirmizis, D., Papagianni A., Dogrammatzi F., Efstratiadis G., & Memmos D. (2013).  Anti-inflammatory effects of simvastatin in diabetic compared to non-diabetic patients on chronic hemodialysis.. J Diabetes. 5(4), 492-4.
Deftereos, S., Giannopoulos G., Angelidis C., Alexopoulos N., Filippatos G., Papoutsidakis N., et al. (2015).  Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study.. Circulation. 132(15), 1395-403.
Sfoungaris, D., Magdalini M., Patoulias I., Panteli C., & Valioulis I. (2018).  Antimesenteric gastrointestinal tract duplication undergoing non-ulcerative perforation.. Rom J Morphol Embryol. 59(4), 1275-1278.
Kontou, A., Sarafidis K., & Roilides E. (2017).  Antimicrobial dosing in neonates.. Expert Rev Clin Pharmacol. 10(3), 239-242.
Chatedaki, C., Voulgaridi I., Kachrimanidou M., Hrabak J., Papagiannitsis C. C., & Petinaki E. (2019).  Antimicrobial susceptibility and mechanisms of resistance of Greek Clostridium difficile clinical isolates.. J Glob Antimicrob Resist. 16, 53-58.
Tolikas, A., Tsakos E., Gerou S., Prapas Y., & Loufopoulos A. (2011).  Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.. Hum Fertil (Camb). 14(4), 246-53.
Piouka, A., Farmakiotis D., Katsikis I., Macut D., Gerou S., & Panidis D. (2009).  Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.. Am J Physiol Endocrinol Metab. 296(2), E238-43.
Apostolidis, A. (2015).  Antimuscarinics in the Treatment of OAB: Is there a First-Line and a Second-Line Choice?. Curr Drug Targets. 16(11), 1187-97.
Poulas, K., Koutsouraki E., Kordas G., Kokla A., & Tzartos S. J. (2012).  Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine.. J Neuroimmunol. 250(1-2), 94-8.
Lekakis, J., Dimopoulos M., Nanas J., Prassopoulos V., Agapitos N., Alexopoulos G., et al. (1997).  Antimyosin scintigraphy for detection of cardiac amyloidosis.. Am J Cardiol. 80(7), 963-5.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.